We are live on ! Find out more
MDCXW icon

Medicus Pharma Warrant

7 hedge funds and large institutions have $33K invested in Medicus Pharma Warrant in 2026 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

13,728% more capital inflows, than outflows

Capital inflows: $24.3K | Capital outflows: $176

75% more funds holding

Funds holding: 4 → 7 (+3)

5.9% more ownership

Funds ownership: 11.28% → 17.18% (+5.9%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
7
Holders Change
+3
Holders Change %
+75%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$176

MDCXW Hedge Fund Activity: Q3 2026 in Review

7 of the 8,184 institutional investors tracked by Wall St. Rank reported a position in Medicus Pharma Warrant (MDCXW) for Q3 2026, worth a combined $33K — down 48% from $63.6K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new MDCXW positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Private Advisor Group, opening a new position worth an estimated $18.1K. The largest seller was UBS Group, cutting an estimated $176.

  • 7 institutional investors held Medicus Pharma Warrant (MDCXW) as of Q3 2026, up from 4 in Q2 2026.
  • Funds reported $33K of Medicus Pharma Warrant stock for Q3 2026, down 48% quarter-over-quarter.
  • 3 funds opened new Medicus Pharma Warrant positions in Q3 2026 and 0 closed out, a net change of +3 holders.
  • The largest Medicus Pharma Warrant buyer in Q3 2026 was Private Advisor Group, an estimated $18.1K added.
  • The largest Medicus Pharma Warrant seller in Q3 2026 was UBS Group, an estimated $176 sold.

Based on aggregated 13F filings for Q3 2026.